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. The pr<:>blem. The Pieron Phenomenon is the produc-
tlon of sleep In fully rested animals after a ventricular
infusion of cerebrospinal fluid (CSF) from sleep deprived
animals. According to the humoral theory of sleep, this
is caused by the presentation of some sleep promoting sub-
stance (factor S) which depresses the brain. The somnolence
produced is accompanied by an increase in slow wave sleep
(SWS). Other factors which also increase SWS, such as
exercise, may also do so through some mechanism involving
the accumulation of factor S. Although this molecule is
known to be a polypeptide with a molecular weight under 500,
the structure remains unknown, greatly complicating the
exploration of these relationships.
Procedure. Schedules and equipment which permit
controlled administration of exercise and sleep depriva-
tion in dogs, and techniques for the removal and storage
of CSF were developed and described. An assay procedure
was described which makes use of the Pieron Phenomenon and
the diurnal cycle of locomotor activity in rats.
Summary. This paper describes several techniques
which, when appropriately combined, can be incorporated
into subsequent experiments measurin~ the effects of a .
variety of parameters on the productlon of sleep promotlng
substance in the CSF.
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1INTRODUCTION
The "hypnotoxin" or "humoral!! theory is one of
three proposed sleep mechanisms. It postulates the produc-
tion and accumulation of certain neuroactive substances,
supposedly end product of metabolism, either in the tissues
in general, or in the brain. The brain is depressed when
the concentration of such substances reaches a threshold
level. The gradual removal of these substances during
sleep leads to the return of wakefulness. This paper deals
with a class of observations related to this theory called
the Pieron Phenomenon.
More than 60 years ago, Henri Pieron infused cer-
ebrospinal fluid (CSF) from dogs deprived of sleep for
relatively long periods of time into the ventricular system
of normal animals. The recipient dogs showed sleep, or
significantly depressed activity, for several hours follow-
ing the infusion. It was proposed, in keeping with the
humoral theory, that some hypnotoxic substance was produced
and released into the CSF of the animal during sleep depriva-
tion. The subsequent infusion of this "sleep deprived" CSF
into the recipient animals caused changes in their behavior
due to the high concentration of the hypnotoxin. However,
because Pieron's techniques involved inflicting a consider-
able amount of stress upon the animals, his results were
regarded as possible artifacts of the procedure, and the
2significance of the Pieron Phenomenon was questioned.
J. R. Pappenheimer devised experiments that con-
firmed the essential observations described by Pieron under
conditions involving much less stress to the experimental
animals. His results indicate that there is a gradual re-
lease of some humoral factor, dubbed factor S by Pappenheimer,
into the CSF during the first 24 hours of sleeplessness,
suggesting that it may somehow regulate the normal cycle of
sleep and wakefulness. Furthermore, CSF collected from
goats promoted sleep in rats and rabbits, suggesting that
the same, or similar, humoral factor may operate in various
mammalian species. Though the factor S molecule itself has
not yet been identified, the physiological mechanism for
the production, release, and accumulation of this substance
seems a fruitful area for research.
Sleep deprivation has been shown to cause an in-
crease in the amount of slow wave sleep (SWS) in the reci-
pient animals mentioned above (pappenheimer, 1976), and
in the amount of compensatory SWS in the donor animals
(Berger and Oswald, 1962). According to the humoral theory,
both operate through some mechanism promoting the accumula-
tion of factor S. Other factors have also been associated
with increased SWS. The normal proportion of SWS has been
shown to be greatest in infancy and childhood (Roffwarg et
al., 1964), progressively less from sixteen to sixty
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(Williams et al., 1966), and least in old age (Kale.s et 1a .,
1966). It has been proposed that SWS is related to fatigue
(Roffwarg et al., 1966), to physiological repairative pro-
cesses and energy build up (Fisher,. 1965), and to some debt
incurred during wakefulness (Oswald, 1962). Finally, work
has been done suggesting a general positive relationship
between exercise and the amount of SWS in a night1s sleep
(Baekeland and Lasky, 1966).
Since factor S accumulation, as indicated by sleep
deprivation, is accompanied by increased SWS, it is possible
that the other SWS increasing parameters mentioned above
may also be related to the factor S mechanism. If these
parameters increase SWS through some mechanism related to
factor S, then the overflow of factor S into the CSF may be
adequate to allow detection by infusing CSF from donor
animals into recipients and quantitatively measuring the
effects of the infusion.
Sleep
Deprivation
Other
Parameters
(Exercise,
Age, Stress,
Etc. )
) ?
Increased--~) SWS
Figure 1. possible relationship of sleep depriva-
tion and other parameters to increased SWS, according to
the humoral theory of sleep.
4The purpose of this thesis is twofold. The first
step is to propose an experimental design which evaluates
the relative effectiveness of exerc~se dId .~ an seep eprlva-
tion im promoting factor S production. This is described
in the experimental design section. The second step is to
develop, build, and test all of the hardware and techniques
which are necessary to carry out this experimental design.
This is described in the Methods and Materials section and
the Results section.
EXPERIMENTAL DESIGN
The project consists of two parts. The first en-
tails manipulation of the experimental parameters of exer-
cise and sleep deprivation to produce a characteristic
concentration of factor S in the eSF of the donor animal.
The second part is an evaluation of the sleep promoting ten-
dency of a sample of this eSF, accomplished by infusing it
into the ventricular system of recipient animals and
measuring the resultant changes in sleep patterns .. Because
Pappenheimer showed that factor S is not significantly
species specific in mammals, considerable freedom can be
exercised in the choice of animals to be used. Dogs are
used in this design as donors because of the ease of
handling them and the relatively large volume of obtainable
eSF. Rats are used as recipients because of their well
defined diurnal cycle of sleep and activity.
i
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The procedural path of the factor S produced in the
donor animals is illustrated in Figure 2. The rate of pro-
duction or accumulation of factor S in the eSF is a func-
tion of the procedure the donor dog experiences. Before
either the brain can metabolize the factor S or the concen-
tration is diluted by normal CSF flow, a 4 ml sample is re-
moved from the cisterna magna and stored at -20°C until
utilized in the assay procedure. Quantitative evaluation
of the effect is accomplished by infusing the sample into
the ventricular system of the recipient animals and measur-
ing the changes produced in their locomotor activity during
the subsequent 24 hour period. This data is compared with
control values for that same rat. In accordance with the
Pieron Phenomenon, CSF from the dog infused into the rat
should cause an increase in the amount of SWS in the rat
and, therefore, a measurable decrease in the amount of loco-
motor activity from normal. The more factor S that is
present in the donor eSF, the greater the depression of the
rat1s activity.
Acclimation period. It is essential to stabilize
the sleep-wakefulness cycle of the donors so that the onset
of wakefulness and sleep can be closely estimated. The
animals are placed on a 12-12 hour light-dark cycle, the
light phase beginning at 0600 and the dark phase at 1800.
This cycle is maintained throughout the experiment with food
d 1 , d ad l·.ib The onset of wakefulness, oran water supp le _.__.__ 0
____________~ Withdrawal and
Storage of CSF
Measurement
of
Locomotor
Activity
Evaluation
:> Sample
--------~
--------~
--------~
--------~
Rat
-----------~
-----------~
-----------~-----------~
Dog
Control--------------------~
Exercise-------------------~
Sleep Dep.-----------------~
Ex. Sleep Dep.-------------~
E.xperimental
Procedures
The donor Dog undergoes
the procedure involving
the experimental
parameter.
The CSF sample is
removed and stored.
The CSF sample is
evaluated by infusion
of the sample into the
ventricular system of
rats and the measure-
ment of locomotor
activity.
Figure 2. The procedural path and treatment of CSF through donor and
recipient animals.
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the time from which the number of hours since last sleep
will be calculated, is designated as the beginning of the
light phase. The dogs are acclimated to this cycle for a
two week period to allow adjustment of their diurnal cycles.
Manipulation and Comparison of Experimental
Parameters. The following guidelines are used in designing
experimental procedures. (I) All procedures begin at 0600.
This assumes that when the lights come on at 0600, the dog
awakens from a complete night's sleep and has a minimal
concentration of factor S in its CSF. (2) To eliminate
variation between donor CSF samples, each dog supplies a
control CSF sample as well as one for each experimental
procedure, and the data obtained is compared only with data
,
from that same dog. (3) The order in which each dog experi-
ences these procedures is randomized to eliminate the
possible influence of order or learning on the data. (4)
Procedures which are to be compared must be identical
except for the variation of one experimental parameter.
(5) A dog which has experienced a dural puncture does not
undergo another puncture for a two week period to prevent
the development of adhesions and to insure full recovery.
A control and three experimental procedures designed
to explore the relationship of exercise and sleep depriva-
tion to the factor S mechanism are described below.
Figure 3 further illustrates these procedures.
28
Control
,
Exercise
Sleep Dep.
EX-Sleep Dep.
a 12 24 36
Hours of Sleeplessness
Key c=J Normal Activity
~ Control
0600 1800 0600 1800
~ Sleep Dep.
~ Ex-Sleep Dep.
Figure 3. Amounts, types, and times of stimuli
for experimental procedures.
Control. At 0600, the lights in the animal room
are turned on, awakening the dog. The animal is confined
to its cage for the duration of the light phase with food
and water supplied ad lib. At 1800, 4 ml of CSF is with-
drawn from the cisterna magna and frozen at -20°C.
Exercise. The dog is awakened at 0600 and immedi-
ately placed on the treadmill for exercise. Each 60
minute exercise session is followed by a 60 minute rest
period, during which the dog is returned to its cage. This
exercise-rest cycle continues throughout the light phase,
accumulating a total of six hours of exercise. At 1800,
9
4 rol of CSF is removed and frozen.
Sleep Deprivation. The dog is awakened at 0600 and
confined to its cage until 1800·.· .as· .l.n the control procedure.
The dog is then dep' d frJ.ve 0 sleep during the following 24
hours. At 1800 of the following day, 36 hours after the
donor last Slept, 4 ml of CSF is removed and frozen.
Exercise and Sleep Deprivation. The dog awakens at
0600 and until 1800 is confined to its cage as in the con-
trol procedure. From 1800 to 0600 of the following day,
the normal dark phase, the dog is deprived of sleep. At
0600, the animal is placed on the treadmill and undergoes
the exercise-rest cycle described for the exercise pro-
cedure. At 1800 of the second day, 36 hours after the dog
last slept, 4 ml of CSF is removed and frozE?n ..
This project is designed to compare the sleep
promoting effectiveness of CSF obtained from each of the
experimental procedures on recipient rats. Table 1 pre-
sents the amount of time devoted to each parameter during
the above procedures. The effect of exercise on the produc-
tion of factor S is observed by comparing the exercise and
control procedures. Data from the sleep deprivation pro-
cedure is compared with the control data to confirm the
basic observations of the Pieron Phenomenon. Comparison of
the exercise and sleep deprivation data with the control
will provide information about the relationship of these
stimuli to the factor S mechanism, and about the potency
10
of exercise, as comp d
. are· to sleep deprivation ., ~n promoting
sleep. Finally, a comparison of the data from the sleep
deprived and exercise-sleep deprived groups with the con-
trol explore the possible cumulat;ve effect
.... of exercise
and sleep deprivation in promoting sleep.
3&
Table 1. C~mparative amounts of exercise and sleep depriva-
t~on for the experimental procedures.
Experimental
Procedure
Control
Exercise
Sleep Dep.
Ex-Sleep Dep.
Amount of
Exercise (hrs)
o
6
o
6
Amount of
Sleep Dep. (hrs)
12
12
36
36
Assay of Sleep Promoting Factor in eSF. A fairly
simple assay of the sleep promoting characteristics of a
CSF sample was devised by Pappenheimer based upon the
amount of locomotor activity rats exhibit in the light and
dark phases of their diurnal cycles. Rats sleep about 65%
of the time during the day and 30% of the time at night.
The assay involves the infusion of the suspected sleep
factor two hours before the beginning of the dark phase.
The exogenous or non-native sleep inducing substance over-
comes the animal's natural wakefulness, causing it to sleep
more and, hence, be less active at night.
a a ii
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As shown by Pappenheimer with simultaneous record-
ings, the reduction of locomotor activity following an
infusion of CSF from sleep deprived animals is associated
with an increase in the duration of SWS measured on the
basis of continuous EEG recordings. This assay of loco-
motor activity is useful in screening large numbers of
samples where EEG measurement is inconvenient or impracti-
cal.
A slightly modified form of Pappenheimer's tech-
nique is used in this project. The rats are acclimated to
a 12-12 light-dark cycle similar to that of the dogs. Each
rat is implanted with a ventricular guide tube and allowed
to recover before control locomotor activity data is co1-
lected. The CSF sample is infused into the lateral ven-
tricle of the rat just prior to the dark phase of its
diurnal cycle. The rat is returned to its cage, and
locomotor activity is measured for the following 24 hours.
The data collected is compared with control data from that
same rat and analyzed for significance.
METHODS AND MATERIALS
Factor S Donors
Delivery of Experimental Parameters. The apparatus
used to deliver each experimental parameter must not only
be durable and able to perform effectively, but also must
p:s g
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insure uniformity of delivery between animals and eliminate
novel stimuli.
Sleep Deprivation Device. A device similar to that
used by Pappenheimer with goats, which deprives dogs of
sleep by forcing them to remain in a standing position, was
devised by this researcher. If the animal lies down, a
mild shock is delivered to its tail through attached
electrodes. When the dog rises, the stimulation ceases.
4 A dog wear i ng· the harness and shockFigure .
plates of the sleep deprivation device.
. and. operation of this device isThe constructlon
A cable system rigged across theillustrated in
ceiling of the
through this a
Figure 5.
cage suspends a pulley from
cable passes from the dog's
the center;
harness to a
Sl' t ua t ed outside of the cage.mercury switch When the dog
Pul l ed and the mercury switch islies down, the cable is
Mercury Switch
JUS
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Buzzer and
elapsed time
meter
Shock Plates
Harness
t223&
Figure 5. Construction and operation of the sleep
deprivation device.
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closed. It is returned to an open position by a spring as
the animal rises. The switch completes a circuit contain-
ing a buzzer, an elapsed time meter, and a stimulator.
When the switch is closed, the buzzer sounds and a shock is
delivered through electrodes attached to the animal's tail.
The elapsed time meter measures the amount of time that
current is delivered to the animal.
A connector permitting 360 0 rotation of the tail
plate wires around the main cable eliminates tangling and
displacement of the tail plates. All wires are passed to
the outside through conduit to prevent the dog from chewing
through them. The shock plates, prepared from common
laboratory EKG plates, are coated on the edges with a
silicone sealer to prevent current flow in the event they
come into contact with each other. They are attached to the
dog's tail after the area has been shavedj EKG paste is
applied to promote conduction through the skin. The plates
are to be secure but not interfer with the circulation of
the tail. (See Figure 6.)
Exercise Apparatus. A treadmill is used to deliver
uniform amounts of exercise to the dogs. It is constructed
to run the animal at five mph, and is equipped with a
rheostatic switch which allows the floor speed to be slowly
increased from zero to five mph. The running surface
measures 110 em by 48 em. The treadmill is equipped with a
. 92 em by 51 em by 69 em with doors on the
stall measurlng
• as
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front and back. The ceiling consists of bars which enable
the trainer to work with the dog while the treadmill is
e
running. [See Figure 7.).
Figure 6. Proper placement of shock plates on
dog's tail.
Tre admi l l of the design and dimensionsFigure 7.
described for this project.
£.2$
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Figure 8 illustrates the safety cable wh;ch•..
... passes
from the front of the cage to the dog's harness. This sup-
Por t s the animal should bl
. . pro .ems arise and he be unable to
keep up with the treadmill.
Figure 8. The safety cable, passing from the front
of the cage to the harness.
The dogs are exercised for 30 minutes three times a
week throughout the experiment to maintain physical condi-
tion.
CSF Withdrawal and Storage. The procedure used to
remove CSF from the donor animals must meet several cri-
&
teria. (1) To minimize any influence the withdrawal pro-
cedure might have upon the factor S mechanism, the process
must be brief. (2) Because the donor animals are used for
several cisternal punctures, it must be relatively safe.
- ,iJij, &S_ 2d2 'is •
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(3) For convenience, it must require a minimum of prepara-
tion for the animal. (4) It can use no drugs that cross
the blood-brain barrier before the sample has been with-
drawn. Such drugs could pass into the CSP and alter the
effect of the hypnotoxin infused into the rats.
The techniques used in previous projects to withdraw
CSP from the donor animals are unsatisfactory for use in
this project. The technique used by Pieron entailed
puncturing the atlanta-occipital membrane at the base of
the brain without anesthetics: the animals struggled
violently and often collapsed or were partially paralyzed
after the puncture. Because of the injury risk factor
involved with this technique, it cannot be used in its
present form.
Pappenheimer devised techniques for perfusing the
cavities of the brain in specially prepared unanesthetized
goats. This technique allows the membranes over the
cisternal cavity to be punctured at will through a chroni-
cally implanted guide tube. eSp'can then be withdrawn
continuously without disturbing the animal. The horns of
the goat provide mechanical protection for the guide tube
and serve as an anchoring site for the infusion and with-
drawal apparatus. Since this project utilizes dogs as
d "I the· a.nchoring site is absent negating the useonor an ama s ,
of this technique.
2 isa
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In this laboratory, a technique has been devised
using the basic aspects of Pieron's procedure_~ The major
problem wi th his technique, the andmal,~ struggling during
the CSF withdrawal, is overcome by the administration of
curare. Curare is not an anesthetic and is not used as
such here. Curare paralyzes the dog by blocking the neural
synapse, and does not cross the blood-brain barrier. Its
effects are reversible with other drugs. It is used to
avoid the excessive struggling the animal is likely to make
to the novel experience of the cisternal puncture. This
technique fulfills the aforementioned criteria for the
withdrawal procedure and affords several advantages over
those previously mentioned. First, curare is fast acting.
It paralyzes the animal within three minutes of its admin-
istration when given in the proper dosage. Second, it is
progressive in action affecting different muscle groups at
different rates. The occular and facial muscles are the
first affected, followed by the head and neck muscles, the
limb muscles, and finally the respiratory muscles five to
seven minutes after the first signs of paralysis. Third,
the effects of curare are reversible with an antidote.
Neostigmine rapidly reverses the effects of the curare when
. the proper dos.·age with few side effects.administered ~n
doe. s not crowd the blood-brain barrier.Finally, curare
This insures that the drug has no effect upon the data.
- LllE 22 ZJ #4 i
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The disadva.ntage of this technique is that because
curare does not affe t th
.. . c e consciousness of the animal, the
dog is awake, though immobile, throughout the withdrawal
process. The discomfort of t·h.··e c~st·er.na.l
... puncture is a
form of stress. Because ~t·
... occurs so near the time of
Once
sample withdrawal, however, its influence upon the CSF
sample is presumed inconsequential.
A list of the materials needed for this procedure
is provided in Appendix 1.
The dog is administered O.15mg/kg of tubocurare
intravenously and observed for the expected effects. If
needed, a second 0.15mg/kg dose may be given in the same
manner.
When the dog is immobilized, the notch between the
atlas and axis is palpated and a spot one cm from the mid-
line is marked. A 20 gauge needle with a sterile 5 ml
syringe is inserted at this point until a "pop" is felt as
the needle passes through the dura mater. To test if the
probe is in cisterna, the"plunger of the syringe is with-
drawn. If the puncture is successful, CSF will pass into
the syringe. If the puncture is unsuccessful, the syringe
will be difficult to draw and no CSF will pass into the
syringe barrel. In this situation, the needle tip is
passed either deeper or shallower and tested again.
a. 4 ml vo Lume ; s wi thdrawn and the needleCSF is obtained, ...
removed.
- 10
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Immediately after the needle is removed from the
cisterna magna, 0.5 ml of 0.1% Neostigmine Methyl Sulfate
is administered to the dog intraveinously. This reverses
the paralyzing effects of the curare. The total time from
the curare injection to 'the administration of the Neostig-
mine must not exceed five minutes, after which the effect
of the curare upon the respiratory muscles is more pro-
nounced and the chances of permanent injury to the dog
resulting from anoxia are greatly increased. After normal
motor control returns, the dog is returned to its cage. The
CSF sample is transferred to a sterile vial, labelled, and
frozen at -20°C.
Factor S Recipients
Activity Cages. The activity cages used in this
project to measure the locomotor activity of rats are a
modified version of those used by Pappenheimer. Each cage,
illustrated in Figures 9 and la, is criss-crossed by two
beams of dim red light focused on photoconductive cells.
When a beam is broken, its photocell triggers a relay
2 Ji
which deflects the pen on a strip chart recorder. When the
r.eturns to its original position.beam is restored, the pen
t adequat e l y separate the pen deflec-To conserve paper, ye
. h speed is set at 1 rom/sec.t10ns, t e paper The record is
. the beam is broken andanalyzed for the number of tJ.mes
restored per hour time period. This information is
2Mi
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separated into six hour .~ncrements starting at 1800.
Strip Chart Recorder
Photoelectric Cells
Dim, red light sources
\
\
\
\
\
\
\
\
,
\
Food
I
I
I
I
~
'I
I
I
9"
Figure 9. Design and dimensions of the locomotor
activity cage.
Construction of the Guide Tube-Infusion System.
Pappenheimer used separate techniques for the implantation
of the ventricular guide tubes in rats and the measurement
of the length of ventricular probe needed for each rat. A
technique was devised which incorporates both of these
procedures into one.
is
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Figure 10. Top view of activity cage.
Guide Tube. The guide tube is built from a #440
brass bolt. The bolt is cut into 6 rom lengths and the
center of each is drilled out to a diameter of 1/16 on an
inch. Care is taken to insure that all threads, especially
the starter threads at either end, are operational. (See
Figure 11.)
~~tJ
cl~
Figure 11. construction of the guide tubes.
iii
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Cap.. The cap, when screwed onto the guide tube
following the implantation procedure, protects the dura from
the outside. It is removed only for ventricular infusions
or cleaning of the guide tube. The cap is prepared from a
#440 brass bolt and a #440 brass nut. The bolt is in-
serted into the nut one turn and the two are soldered to-
gether. The bolt is cut 3 mm from where it makes contact
with the nut. Extra solder and the rough edges of the
assembly are filed smooth. (See Figure 12.)
Figure 12. Construction of the guide tube cap.
Infusion Probe. The infusion probe is constructed
from a #440 brass bolt, two #440 brass nuts, a 5/8 inch 25
n·e e d l e , and. a durable rubber adhesive.gauge
The brass bolt is drilled out as above to a
diameter of 1/16 of an inch and inserted one half of one
turn into one of the brass nuts. The two are soldered
bolt sawed off as close to the nut astogether and the
possible.
from the
the nut.
of the screw and solder protrUdingThe remainder
Wl.' thin 0.5 rom of the surface ofnut is filed to
The construction of this prepared nut is
.. :a
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illustrated in Figure 13.
cn
,
B. I C. Dotal
~ Eo(!jj
Prepared
nut
Figure 13. Construction of prepared nut.
The prepared nut and a second nut are arranged on a
brass bolt so that they are touching and glued together
using the rubber adhesive. When dry, this screw assembly
is removed from the bolt, as in Figure 14.
D.
B.
Eo~:::::
~small
hole
assembly
hole
Figure 14. Construction of screw assembly.
2 &4'
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The needle and plastic collar of the 25 gauge
needle are separated avoiding damage to either piece. A
piece of white plastic adhesive on the needle will be used
as a stop preventing the needle fram moving in the infusion
probe assembly. The blunt end of the needle is inserted
into the large hole of the screw assembly until the stop
makes contact with the piece of the #440 brass bolt in the
prepared end of the screw assembly. The blunt end of the
needle should pass through the 1/16 inch hole and protrude
one to three millimeters past the surface of the screw
assembly. The plastic cap is repositioned on the blunt end
of the needle and pushed flush with the surface of the
screw assembly. The assembly is glued to the cap with the
rubber adhesive.
Each infusion probe is matched with a guide tube,
labelled, and screwed together until the guide tube cannot
be inserted any further into the probe. The end of the
needle shaft is filed so that only 3 rom protrude from the
base of the guide tube. (See Figure 15.1
Infusion Tubing. polyethylene tubing with an inner
diameter of 0.86 mm and an outer diameter of 1. 27 nun is
equipped with adaptors at either end to attach. to the
infusion probe and T-cha!nber.
One end of the tubing is equipped with a male end
which fits into the
seen in Figure 16.
plastic cap of the infusion probe as
The barrel of a one milliliter syringe
, I
•;r
,
"
,
I
Guide
Tube
A.
:a
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Figure 15. Construction of the infusion probe.
is cut 2 em from the tip of the needle end. The tubing is
inserted through the cut end until the end protrudes past
the end of the tube tip 1 em. Rubber cement is squeezed
through the sawed end of the syringe barrel around the
tubing until it Begins to pass out of the tuBe tip around
the tubing. The cement must pass completely through the
tube to the end to insure that no air pockets develop.
Once the cement is dry, the extra tubing is cut flush with
27
the tip of the syring.eb
. arrel and the tub· J.l1'g. La
... checked
for clear passage.
The other end f ko ti4e tubing is connected to an 18
gauge needle and cemented with rubber adhes{ve
... as seen in
Figure 17.
A. c. D.
Figure 16.· Construction of infusion probe adapter
usion on infusion tubing.
1 "
;1
,
B. C.
~~
..",.,..
,-
..
"
,"
: 1
Figure 17. Construction of T-chamber adapter of
infusion tubing.
T-chamber. The T-chamber serves as a co.mmon path-
way for the production and measurement of pressure of the
infusion system. It connects the infusion pump, infusion
a28
tubing, and pressure transducer pe.rmitt· oj g
ok measurement of
minute changes in the pressure of t.he flufd bei g
ok delivered.
It is constructed from two syringes, on 10. ml d 5 Ian . one m,
one 18 gauge needle, one 20: gauge needle, and silicone
adhesive.
Both syringes are cut 10 rom fram the male end of
the barrel and a 1/16 inch hole drilled 5 nun from the sawed
end in each. With the sawed ends facing each. other, the
small syringe is inserted into the large syringe and the
drill holes are aligned. An 18 gauge needle is inserted
through both holes with the tip protruding into the lumen
of the 5 ml syringe. Silicone adhesive is squeezed be-
tween the two syringe barrels filling the space between
them, but not passing into the. lumen of the 5 ml syringe.
Sealer is also applied around the needle from where it
enters the 10: ml syringe barrel to the plastic collar.
When the sealer is dry, the 20 gauge needle, which will re-
ceive the needle from the microsyringe , is pos.Lt.Lorred on
one of the male ends as seen in Figure 18.
OperatLon ofthe.Guide-Tube-Infusion System
Filling the System. After the Ln f us i.on system is
assembled as illustrated Ln Figure 19, the open end of
. With
. t·ub';ng·';s p Laced into a saline reserVOl.r.the infus~on· ........ ....
the control syringe is gently with~both stopcocks open,
sall."n e through the tubing fillLng thedrawn drawLng
T-chamber and pressure transducer. When they are full and
10
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t 1/16"
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Figure 18. Construction of T-chamber.
Microsyringe
Infusion Tubing
- T-chamber
Pressure
N---- Transducer
Control
Syringe
Figure 19.
components.
Proper assembly of all infusion system
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all bubbles are evacuated, stopcock il is closed. To fill
the microsyringe, the open end of the infusion tubing is
capped and the plunger is removed from the microsYr:i.nge.
Stopcock #1 is reopened, and. the control syringe Pushed in,
driving saline through the 20 gauge needle into the micro-
syringe. When the syringe is completely filled, stopcock
#1 is closed. and the microsyringe plunger reinserted. The
end of the infusion tUbing is uncapped and. placed into
saline allowing equalization of pressure in the system.
System Sensitivity. The critical feature of the
infusion technique is the ability to detect minute pressure
changes in the fluid being delivered as the infusion probe
tip penetrates the lateral ventricle. The recorder must be
iEiiii
suff sensitive to indicate a change in pressure re-
suIting delivery of 0.001 m:m. of fluid. Since
are so close to zero i calibration is not practical.
Checkinq the Svstem for Leaks. The end of the
"'" oOiO,
and, stopcock #1 closed, a
of the microsyringe, causing a
measurable
this
pressure of the system as de-
Delivery is halted and
for at least two minutes. The
drop pressure. toward
zero, the system a
a
a two
not ect
is of
""",n.oration
scm-M
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of the system. A noteable drop must be traced and plugged
using silicone sealer.
Loading the System. During this process, the
sample to be infused is loaded into the infusion system
for delivery.
With the system filled and the probe tip of the
infusion tubing in the saline reservoir, the microsyringe
plunger is depressed expelling into the reservoir a volume
equal to the contents of the syringe barrel. The probe tip
is removed from the reservoir and placed into a vial con-
taining the substance to be infused. This is drawn into
the infusion system by pulling back the plunger of the
microsyringe to the desired volume. The probe tip is left
in the infusion sample vial until the time of infusion to
prevent air bubbles from entering the tubing.
Infusion Delivery. The infusion system is equipped
with a syringe pump mechanism in the form of a motor drive
attachment to the microsyringe. This device features
variable delivery rates and promotes uniform delivery of
the infusion sample.
Implantation Procedure. The materials used in the
guide tube implantation procedure are listed in Appendix 2.
Male rats weighing 225 to 275 gm are anesthetized
using a 40 to 50 mg/kg dosage of Nembutal injected intra-
peritoneally. The first injection of 40 mg/kg is admin-
istered, and if needed, a second injection of 10 mg/kg is
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given.
The rat's head is shaved from the base of the skull
to the forehead, and placed into a stereotax.1.·c apparatus.
A midsaggital incision 2 em long is made and the skull is
exposed. A 1.2 rom diameter hole is drilled 1 rom lateral
and 1 rom posterior to the bregma with care taken to avoid
damage to the dura. This hole is shaped to permit threading
of the guide tube into the skull.
The infusion probe-guide tube set is screwed to-
gether, the infusion system is primed, and the combined
probe-guide tube assembly is started into the hole. When
the threads of the guide tube first firmly bite into the
bone, inward progress is stopped, and the infusion pump
started at a rate of 6.6 ~l/min. Because of the density of
the brain tissue in which the probe tip rests, the system
is effectively blocked, and as the pump continues to deliver
fluid, the pressure of the system increases. When the
pressure change causes a 1 cm deflection of the pen on the
strip chart recorder, the infusion apparatus is slowly
screwed into the skull at a rate of ~ turn per second. Slow
inward progress will reduce the chance of overshooting the
ventricle. When the tip penetrates the lateral ventricle,
the blockage at the end of the guide tube is removed, and
g'i":ZZ;;;
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the pressure dramatically drops to almost zero. Inward
progress is halted at this point. To confirm penetration
of the ventricle, the infusion pump speed is doubled for
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one minute. A smooth and relatively even pressure line is
characteristic of even flow through the ventricular system.
With ventricular penetration confirmed, the guide tUbe is
held with a hemostat and the infusion probe unscrewed from
the assembly leaving the guide tube imbedded in the skull
at this specific depth. This permits rapid and accurate
relocation of the lateral ventricle with that same infusion
probe.
Starter holes for two anchor screws are drilled in
the midsaggital plane 6 rom anterior and posterior to the
guide tube. The anterior screw is implanted with half of
the shaft length protruding above the skull and the poster-
ior screw with 2/3 of its length above the bone. Dental
resin is applied around the base of the guide tube and
anchor screws securing the three as a unit.
Powdered antibiotic is applied and the area sutured
bringing the edges of the incision into contact with the
resin border. The guide tube is gently irrigated with
saline to float out any debris and is capped. The rat is
returned to its cage to recover for a two week period during
which the light-dark cycle is maintained.
Infusion Procedures
Handling and Maintenance of the Guide Tubes. The
infusion procedure entails the insertion of probes into the
lateral ventricles of unanesthetized rats. Pappenheimer
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showed that these animals will permit this procedure with-
out struggle once accustomed to being handled. It is,
therefore, imperative that the rats be accustomed to handling
and activity in the area of their guide tube for this tech-
nique to be successful.
The guide tubes must be cleaned twice a week to pre-
aM
vent blockage. In this procedure, the rat is removed from
its cage and handled for several minutes. The guide tube
cap is removed and the guide tube slowly irrigated with
warm saline with care taken to avoid puncturing the dura.
When the tube is clear, the cap is replaced and the rat re-
turned to its cage. This procedure also aids in familiar-
izing the animal with handling.
Ventricular Infusion in Rats. The intraventricular
infusions are conducted between 1530 and 1700 hours. The
infusion system is filled, tested, and loaded with 0.15 ml
of the infusate. As in the guide tube cleaning procedure,
the rat is removed from its cage and handled briefly, and
the guide tube cap is removed. The tube is irrigated with
warm saline to insure clear passage of the probe. with
the infusion pump delivering at a rate of 6.6 ~l/min, the
infusion probe is started into the guide tube. As the
probe tip enters brain tissue, signalled by a slow increase
in the pressure of the system, inward progress is delayed
to accumulate sufficient pressure to deflect the pen 1 em.
When this pressure has been attained, the probe is inserted
axs:a, i ..iii
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by screwing the infusion apparatu.s onto the guide tube at
a rate of ~ turn per second. Infusion pressures are moni-
tored continuously as an indication of probe tip location
in the brain. Entry into the ventricle, signalled by a
sudden drop in the accumulated pressure, should Occur just
prior to the point where the probe cannot be turned farther
onto the guide tube. Care must be taken not to overturn
the assembly as the guide tube may become dislodged from
the resin, altering probe tip position.
When entry is confirmed, as described in the im-
plant procedure, the infusion rate is cut to 3.3 ~l/min
and the remaining portion of the infusate delivered over
the next 30 minute period. During the infusion, the rat is
either held or placed in a storage cage and observed. When
the process is completed, the probe is removed, and the
guide tube is capped. The rat is then returned to its
cage and allowed to settle down to its normal daylight state
of relative quiescence. Locomotor activity is not recorded
until 1800 when the dark phase of the diurnal cycle begins.
Each rat will be allowed to recover fully from the
effects of an infusion before being used for another assay.
The criterion for complete recovery is the resumption of
normal locomotor activity for at least two days and nights.
Confirmation of Guide Tube Placement. A technique
has been devised by Pappenheimer to insure proper guide
tube placement and to verify that the infusate has been
-·.Pi1.. &£3 _
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reaching the entire ventricular system. Each rat will be
used for up to five infusions. Two days after the I.as.t· .l.n-
fusion procedure, each rat will be sacrificed fifteen
minutes after being infused with 0.15 M saline and methylene
blue. The brain is immediately removed, sectioned to ex-
pose the ventricles, and examined to insure that the dye
reached all four ventricles.
RESULTS
Factor S Donors
Sleep Deprivation Device. Familiarity of the dogs
with this apparatus before the experimental procedures
eliminates much initial stress by insuring that the dog has
learned to avoid being shocked by standing. Three dogs
were placed in the device for a period of six hours, during
the light phase of their diurnal cycle, late in the
acclimation period. It was found that after being familiar-
ized in this manner, the animals learned, usually within
the first two hours, that a shock is avoided by remaining
in a standing position, and carefully avoided lying down in
subsequent sleep deprivation procedures. The average time
that current was delivered was nine minutes of the six hour
period. No signs of injury of change in attitude toward the
handlers was observed following this process.
This sleep deprivation apparatus was used to deprive
several dogs of short periods of sleep. Extended sleep
a 4WZ:i¥!i [
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deprivation was conducted on two dogs, each being deprived
of 36 hours of sleep. The average time that current was
delivered to these acclimated animals was 15 seconds for
the entire procedure.
Because situations can arise which allow the dog to
sleep, such as displacement of the shock plates, it was
necessary to remain within earshot of the cage buzzer When
conducting sleep deprivation procedures. If the animal
sleeps, the data is rendered unacceptable. By remaining
near, one can rectify problems as they arise.
Exercise Apparatus. The treadmill fulfilled the
criteria established for the exercise apparatus to be used
ii·'_
in this project. It provided a method to deliver exercise
that was uniform in both rate and amount. Because it is
used in a controlled environment and manner, the influence
of novel stimuli upon the data is greatly reduced. Four
dogs were exercised, as described in the "exercise" experi-
mental procedure, for six hours of the twelve hour light
phase. Afterwards, the animals appeared fatigued, but were
healthy and responded favorably to handling.
Because the treadmill presents an unnatural form
of exercise and the dogs may initially become confused and
agitated, it is important for the animals to become familiar
with the treadmill. This process was carried out in seven
sessions spread throughout the acclimation period. In the
first session, which usually proved most difficult, the
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treadmill was run for seve.ral ten second intervals to allow
the animal to become familiar with starting and stopping
the device. The following six sessions were increased in
duration from ten minutes to one hour by ten minute incre-
ments. Thirteen dogs were acclimated utilizing this tech-
nique. This process satisfactorily prepared them for the
experimental procedures.
CSF Withdrawal. Tube curare satisfactorily im-
mobilized the dog for the cisternal puncture. Better con-
trol was obtained in cisternal puncture. Better control
was obtained when the drug was administered in two doses,
the second of which is given only if needed. The tubocurare
acted almost immediately once a threshold level in the blood
was reached. The amount of time between the onset of
paralysis and when the drug affected the respiratory
muscles proved adequate in which to perform the cisternal
puncture.
Neostigmine Methyl Sulfate adequately reversed the
effects of the curare. The wagging of the dog's tail is
generally the first indication of the drug's action.
Usually within twenty minutes, the animal regains complete
motor control. Several dosages, ranging from 0.25 to 1.5
mg/animal, were used. It was found that a 0.5 mg/animal
dosage, regardless of the size of the dog, was most effec-
tive. With less than this amount, the effects of the
neostigmine were often either not pronounced or unacceptably
au ¥'Ui. i g'
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slow. When dosages greater than 0.5 mg/animal were given,
overdoses would sometimes occur resulting in death.
A total of twelve cisternal tap procedures- 'were
performed upon eight dogs. Five dogs had one cisternal
puncture, two had two punctures, and one had three cisternal
punctures. No adverse effects became apparent in either
the short or long term with any of these dogs.
The total time from the administration of the first
dose of curare to the complete return of motor control to
normal with the neostigmine ranged from seven to 55 minutes.
The average time was 31 minutes.
storage of eSF. As with Pappenheimer, the eSF
samples were transferred to sterile vials, labelled, and
stored at -20 oe until the assay procedure. The samples
obtained were frozen and thawed several times. No changes
in consistency were observed.
Factor S Recipients
Activity Cages. The activity cages described in
this paper and those used by Pappenheimer differ signifi-
cantly only in the manner in which the data is recorded.
Pappenheimer used a counter system which triggered each
time either of the activity cage photoelectric beams was
broken. This counter was photographed at six hour inter-
vals" providing four numerical values per 24 hour period
upon which to base locomotor activity.
= a;;; &8451: i.1
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The system devised in this laboratory, as described
in the methods section, is superior to Pappenheimer' s in
two respects. First, a permanent and complete record of
each individual beam break is obrained, allowing more
complete analysis of the data if desired. Secondly, be-
cause each light beam is connected separately, the record
gives a gross indication of the rat' s position in the cage.
The disadvantage of the strip chart method is the
amount of time and effort needed to analyze the records.
Each pen deflection, indicating a break in its respective
light beam, must be counted per unit time. Pappenheimer's
system circumvents this by presenting the data in a very
'condensed form.
The data required in this project are not of a
nature which greatly benefit from the additional information
provided by the strip chart method. Therefore, either
method will adequately fulfill the requirements of this pro-
ject.
Guide Tube and Infusion Probes. The guide tube-
infusion probe ayst.em described in this paper provides two
advantages over Pappenheimer's system. First, the design
and construction permits both the implantation of the
guide tube and the measurement of the ventricular depth in
one step instead of two. Second, this design allows uni-
form construction of the guide tubes and infusion probes
rather than custom preparation for each rat.
Ii
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This apparatus satisfactorily permitted repeated
penetration and infusion into the lateral ventricles of
rats.
•
Implant Procedures. This procedure permits
implantation of the guide tube in an average time of 30
minutes. It proved to be consistently simple and Success-
ful. All of the seven rats that were implanted using this
procedure survived.
If the guide tube assembly is not seuurely anchored,
it may pullout of the skull with the first or second in-
fusion. Several modifications of anchoring were explored
before the two screw method similar to Pappenheimer's was
devised. This technique satisfactorily secures the guide
tube for the duration of the project.
Infusion Procedures. The infusion procedures pro~
vide a relatively simple means of rapid relocation and
infusion of the lateral ventricle of rats.
After infusing three rats in this manner, it was
found that the pressure drop, described in the methods,
resulting from the penetration of the probe tip into the
lateral ventricle was obvious and repeatable. The method
used to verify ventricular penetration, in which the
normal infusion rate is doubled, also proved satisfactory.
Methylene Blue Verification. This method, as
described by Pappenheimer, demonstrated flow of the infusate
throughout the entire ventricular system. In the one rat
'.5WtJ@; I
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that was infused in this manner, the methylene blue clearly
stained all four ventricles.
SUMMARY
This paper provides a means of evaluating the
effects of sleep deprivation and exercise upon the produc-
tion of sleep promoting substance in the CSF of dogs. The
relative amount and effectiveness of this substance is
ultimately evaluated, via the Pieron Phenomenon, by compara-
tive activity studies in recipient rats. The project in-
corporates several published techniques, some mOdifications
of those, and several successfully developed new techniques.
When appropriately combined, they can be incorporated into
subsequent experiments measuring the effects of a variety
of parameters on the production of sleep promoting sub-
stance in the esp.
z,
-------1'11111. -1 1. .~ .
43
LITERATURE CITED
Baekeland, R., and R. Lasky. 1966. Exercise and sleep
patterns in college athletes. Perceptual and Motor
Skills 23:1203-1207.
Berger, R. J., and I. Oswald. 1962. Effects of sleep
deprivation on behavior, subsequent sleep, and dreaming.
J. Ment. Sci. 108:457-465.
Fisher, C. 1965. Psychoanalytic implications of recent
research on sleep and dreaming. J. Amer. Psychoanal.
Assn. 13:197-270.
Kales, A., T. Wilson, M. J. Paulson, J. D. Kales, and R. D.
Walter. 1966. Relationships between age and sleep
patterns. Paper presented at meeting of Assoc. for
the Psychophysiological Study of Sleep, Gainesville,
Fla.
Oswald, I. 1962. Sleeping and Waking. Elsevier Pub. Co.,
Amsterdam, New York. 232p.
Pappenheimer, J. R. 1976. The sleep factor. Sci. Am.
235(2) :24-29.
Roffwarg, H., W. C. Dement, and C. Fisher. 1964. Prelim-
inary observation of the sleep-dream pattern in neonates,
infants, children, and adults. In E. Harms (ed.),
Problems of Sleep and Dreams in Children. Vol. II.
Bergaman Pub. Co., New York. n.p.
Roffwarg, H., W. C. Dement, and C. Fisher. 1966. Onto-
genetic development of human sleep-dream cycle.
Science. 152:604-619.
williams, R. L., H. W. Agnew, Jr., and W. B. Webb. 1966.
Relationships between age and sleep patterns. Paper
presented at meeting of Assoc. for the psychophysiologi-
cal Study of Sleep, Gainesville, Fla.
APPENDIX 1
CSF WITHDRAWAL MATERIALS
Tubocurare - 0.1 to 0.3 mg/kg of body weight
Neostigmine Methyl Sulfate - 0.5 ml of 0.1%
solution/animal
3 x 20 gauge needles
sterile storage vial
1 x 1 ml syringe
2 x 5 ml syringe
1 x 10 ml syringe
.4.4 ".f&;I'lI',-
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APPENDIX 2
GUIDE TUBE IMPLANTATION MATERIALS
rat - male, 225-275 gm
Nembutal - 5% solution
1 x I ml syringe and 25 gauge 0.5 inch needle
dental drill and bits
surgical tools
2 x 0.25 inch brass sheet metal screws
stereotaxic apparatus
metric ruler and pen
infusion tubing, microsyringe., pump, T-chamber
strip chart recorder, pressure transducer
2 x 3 way stopcocks
powdered antibiotic
dental resin
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